Project Grant T32DA057926
- This Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to evaluate the relationship between chronic pain and substance use disorders. The $146,922 award, with a project period from December 6, 2024 to June 30, 2026, will support research at Indiana University to: 1) Estimate general and condition-specific associations between chronic pain conditions and substance use disorders/overdose, and 2)...
- This federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop a guided, web-based intervention combining Acceptance and Commitment Therapy (ACT) for chronic pain and Mindfulness-Based Relapse Prevention (MBRP) for substance use disorders. The $188,307 award, effective September 1, 2025 through August 31, 2029, will support the principal investigator Dr. Edwards and her mentorship team at...
- The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $161,517 Project Grant to Northwestern University to establish the Substance Use Research Training Program for Physician Researchers in Emergency Medicine (SUPR-EM). The program aims to enrich research training for emergency medicine residents, supporting their development as physician-scientists who can address substance use disorders in emergency care settings. The 5-year...
- This Cooperative Agreement award from the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), is funded under the Drug Use and Addiction Research Programs (CFDA 93.279). The $1,570,904 award to the University of Pittsburgh will support research to deepen the understanding of the whole-person experience of chronic low back pain (CLBP). Building on the previous HEAL Initiative's BACPAC Consortium, the project aims to determine the...
- This $352,540 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a study to improve understanding of effective anticipatory guidance techniques and design an intervention to prevent postoperative opioid misuse (POM) among adolescent surgical patients. The principal investigator, Dr. Sutherland at the Children's Hospital of Philadelphia (CHOP), will conduct a retrospective cohort study to establish...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is intended to develop and evaluate an adaptive psychological intervention to improve pain management and reduce opioid use following an injury. The $264,995 grant, awarded on September 15, 2025, will fund the optimization and feasibility testing of a two-part intervention. The first part is a 15-minute computerized brief intervention focused on...
- This federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to characterize "pain embodiment" and its relationship to opioid misuse risk in chronic pain patients. The $120,513 award to the University of Utah will leverage neuroimaging techniques to study how the sensory and affective components of chronic pain contribute to "pain embodiment" - the tendency to...
- This $398,393 Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop and test a digital implementation tool called the "Building for Implementation Tool (BUILD IT)." The goal is to increase adoption of Selected and Indicated Prevention Programs (SIPPs) for opioid use disorder by providing organizations, including those with limited resources, with an affordable alternative to...
- The University of Washington was awarded a $1,024,374 Cooperative Agreement by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a large, multi-site pragmatic 3-arm cluster randomized control trial. The project, titled "Equitable Primary Care for Pain Care (EQUIP PC)", aims to adapt an Integrated Behavioral Health in Primary Care (IBH-PC) toolkit to improve equitable access to chronic pain...
- This Project Grant award from the Health Resources and Services Administration (HRSA) under the Mental and Behavioral Health Education and Training Grants program (CFDA 93.732) provides $3,078,081 to Clinica Sierra Vista to develop an Addiction Medicine Fellowship Program in Bakersfield, CA. The program will train a total of 14 addiction medicine fellows over 5 years to provide comprehensive, patient-centered substance use disorder (SUD) treatment in medically underserved areas of Kern County,...
BUILDING AN INTERPROFESSIONAL AND DIVERSE WORKFORCE IN SUBSTANCE USE AND PAIN - PROJECT SUMMARY SUBSTANCE USE-INCLUDING SUBSTANCE MISUSE AND USE DISORDERS-AND CHRONIC PAIN ARE VERY COMMON CONDITIONS IN THE US AND CONSTITUTE AN IMPORTANT PUBLIC HEALTH PROBLEM. SUBSTANCE USE AND CHRONIC PAIN COMMONLY CO-OCCUR, ARE HIGHLY INTERRELATED, AND OFTEN DISPROPORTIONATELY IMPACT MARGINALIZED COMMUNITIES. GIVEN THE DEGREE OF INTERCONNECTEDNESS BETWEEN SUBSTANCE USE AND CHRONIC PAIN, ADDRESSING THESE CONDITIONS TOGETHER IS AN IMPORTANT OPPORTUNITY TO IMPROVE OUTCOMES FOR BOTH. AT THE SAME TIME, IMPACTFUL SCIENTIFIC INQUIRY IS BEST ACCOMPLISHED BY INTERDISCIPLINARY AND DIVERSE TEAMS; THEREFORE, THERE IS AN URGENT NEED FOR RESEARCH TEAMS TO BECOME MORE DIVERSE. THE MISSION OF THIS NEW NIDA T32 TRAINING PROGRAM ENTITLED "BUILDING AN INTERPROFESSIONAL AND DIVERSE WORKFORCE IN SUBSTANCE USE AND PAIN" (BUILD-UP) WILL BE TO PROVIDE PERSONALIZED AND RIGOROUS TRAINING TO POSTDOCTORAL FELLOWS WHO PLAN CAREERS AT THE INTERSECTION OF SUBSTANCE USE AND CHRONIC PAIN. BUILD-UP'S MISSION INCLUDES PRIORITIZING RECRUITMENT OF POSTDOCTORAL FELLOWS FROM DIVERSE BACKGROUNDS, INCLUDING PEOPLE WHO IDENTIFY AS BEING FROM A GROUP EXCLUDED BASED ON ETHNICITY AND RACE, BEING FROM A DISADVANTAGED BACKGROUND, HAVING A DISABILITY, OR BEING LGBT+, AND WILL ALSO RECRUIT INDIVIDUALS FROM A VARIETY OF TRAINING BACKGROUNDS. ONCE ENROLLED, BUILD-UP FELLOWS WILL BE MENTORED ON A LONGITUDINAL RESEARCH PROJECT BY EXPERTS IN THE FIELD FROM THE UNIVERSITY OF PITTSBURGH, A HUB FOR RESEARCH AT THE INTERSECTION OF SUBSTANCE USE AND PAIN; PARTICIPATE IN A RIGOROUS, COMPREHENSIVE CURRICULUM BASED ON CORE CLINICAL AND TRANSLATIONAL SCIENCE COMPETENCIES THAT INCLUDES TAILORED CAREER DEVELOPMENT SESSIONS, THE OPTION TO COMPLETE A MASTER'S OF SCIENCE IN CLINICAL RESEARCH, AND SEMINARS ON PAIN AND SUBSTANCE USE-RELATED TOPICS. FELLOWS WILL COME TOGETHER IN PERSON FOR ANNUAL RETREATS, IN-PERSON CONFERENCES, AND SHORT-TERM RESEARCH EXPERIENCES. A CRITICAL AND INNOVATIVE ASPECT OF BUILD-UP IS THAT THE MAJORITY OF THIS 3-YEAR TRAINING PROGRAM WILL BE CONDUCTED REMOTELY, AS A MEANS TO PROMOTE EQUITY BY REDUCING THE BARRIERS PRESENTED BY HAVING FELLOWS MOVE TO A RESEARCH HUB. THERE ARE FEW TRAINING PROGRAMS AT THE INTERSECTION OF SUBSTANCE USE AND CHRONIC PAIN, AND EVEN FEWER REMOTE POSTDOCTORAL FELLOWSHIP OPTIONS. IN ADDITION TO BEING NOVEL WITHIN THIS FIELD, THIS PROGRAM CAN SERVE AS A MODEL TRAINING PROGRAM FOR OTHERS WHO WISH TO CREATE A DIVERSE WORKFORCE AND BUILD CAPACITY FOR EQUITABLE RESEARCH TRAINING NOT ONLY AT MAJOR HUBS, BUT THROUGHOUT THE US.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 9/23/25 | ||
| Not listed | $339.9k | 7/23/25 | ||
| Not listed | $339.9k | 7/23/25 | ||
| Not listed | $0 | 6/27/25 | ||
| Not listed | $0 | 6/27/25 |